Halma PLC (HLMA), the global safety, health and environmental technology group, has announced that Sharmila Nebhrajani OBE, its Senior Independent Director, will take on an additional non-executive directorship at Genus plc with effect from 1 January 2027. The disclosure was made under UK Listing Rules requirement UKLR 6.4.9(2), which obliges listed companies to declare outside appointments held by directors. The announcement is a routine governance update, though investors will note the additional commitment taken on by one of Halma's most senior independent board members.

Key Points

  • Halma PLC (HLMA) — global safety, health and environmental technology group listed on the London Stock Exchange
  • Senior Independent Director Sharmila Nebhrajani OBE will join the board of Genus plc as a non-executive director from 1 January 2027
  • The disclosure was made in compliance with UK Listing Rules provision UKLR 6.4.9(2)
  • Investors may watch whether this additional board role raises any future questions around director time commitments at Halma

Sharmila Nebhrajani OBE to Join Genus plc Board on 1 January 2027

Halma's announcement confirms that Sharmila Nebhrajani OBE, who serves as Senior Independent Director of Halma plc, has accepted a non-executive directorship at Genus plc, the animal genetics and breeding company. Her appointment at Genus is effective from 1 January 2027. The company made the disclosure in line with its obligations under UKLR 6.4.9(2), a UK Listing Rules provision that requires companies to publicly declare when their directors take on external board roles. No further details regarding her specific responsibilities at Genus plc were included in the announcement.

UKLR 6.4.9(2) Compliance Underpins Halma's Transparent Governance Disclosure

The requirement under UKLR 6.4.9(2) is designed to ensure transparency around potential conflicts of interest and director time commitments at UK-listed companies. By publishing this announcement via the Regulatory News Service, Halma demonstrates compliance with its ongoing listing obligations. Halma operates across more than 45 countries, employing a decentralised model of acquisitive growth focused on safety, health and environmental technology niches. Maintaining robust corporate governance standards is considered a key pillar of Halma's long-term operating model, and timely disclosure of director declarations forms part of that framework.

Nebhrajani's Role as Senior Independent Director Within Halma's Board Structure

As Senior Independent Director, Sharmila Nebhrajani OBE holds one of the most significant independent oversight roles on Halma's board, acting as a sounding board for the Chairman and serving as a point of contact for shareholders who have concerns they cannot resolve through the standard executive channels. Her acceptance of an additional non-executive role at Genus plc, a separately listed UK company active in animal genetics, adds an external commitment to her existing responsibilities. Investors and governance observers may monitor whether her dual role prompts any further board commentary from Halma in forthcoming disclosures.